by Lengea Law | Dec 13, 2024 | Legal Compliance, Risk Management
Medical spa and management company owners should carefully review their professional malpractice and general liability insurance policies every time they are set to renew, at least annually, or when any changes are made to the policy or to your business operations....
by Lengea Law | Dec 11, 2024 | Legal Compliance, Risk Management
In today’s fast-changing workplace, the employee handbook has evolved far beyond being a simple collection of policies.. It is a vital document that reflects a company’s culture, legal compliance, and approach to employee engagement. As we approach 2025, the...
by Lengea Law | Dec 10, 2024 | Legal Compliance
The Corporate Transparency Act (CTA) represents a significant effort to curb financial crimes such as terrorist financing, drug trafficking, and money laundering. By requiring companies to disclose their beneficial ownership information, the CTA aims to close...
by Lengea Law | Dec 7, 2024 | Legal Compliance, State-Specific Regulations
As the calendar turns to 2025, employers and employees in New York must navigate significant changes in employment laws. These updates aim to promote fairness, enhance workplace safety, and ensure compliance with evolving standards. Below is a comprehensive overview...
by Lengea Law | Dec 4, 2024 | Legal Compliance
The weight-loss medication market has been experiencing seismic shifts, with pharmaceutical giants Eli Lilly and Novo Nordisk leading the charge. Recent clinical trial results have added more heat to this competition: Lilly’s Zepbound outperformed Novo’s Wegovy in a...
by Lengea Law | Dec 4, 2024 | Legal Compliance
Semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, is poised to reshape the pharmaceutical and wellness industries as its molecule patent approaches expiration in 2025. While this development is exciting, utility and formulation patents...
